Factors influencing men's interest in gene testing for prostate cancer susceptibility

Duane D. Culler, Judy Silberg, Lauren Vanner-Nicely, Joy L. Ware, Colleen Jackson-Cook, Joann Bodurtha

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Interest in genetic testing for inherited cancer susceptibility is high in the general population. Women at risk for BRCA1 and BRCA2 mutations represent the best-studied population undergoing genetic testing for cancer susceptibility. However, it is unclear whether factors influencing interest in genetic testing in women are directly applicable to men. We designed a study to examine factors associated with men's interest in genetic testing to identify prostate cancer susceptibility. Our sample consisted of 267 men present in waiting rooms of a urology clinic in an urban area. We examined whether the concept of "monitoring" could be used to predict the interest of men in a genetic test for prostate cancer susceptibility. Our results indicated that "monitoring" trait was positively associated with interest in genetic testing in these men, but principally for patients rather than nonpatients. Moreover we found that monitoring was associated with overestimation of risk in those men with prostate cancer. Other factors found to influence interest in genetic testing included recommendation by a doctor, family history of prostate cancer, and cost. This study indicated that interest in genetic testing and estimation of risk is influenced by a complex interaction between both psychological factors (monitoring) and nonbehavioral factors (such as patient status, cost, and doctor recommendation).

Original languageEnglish (US)
Pages (from-to)383-398
Number of pages16
JournalJournal of Genetic Counseling
Issue number5
StatePublished - 2002
Externally publishedYes


  • Genetic testing
  • Men
  • Monitoring
  • Prostate cancer genes
  • Psychosocial issues

ASJC Scopus subject areas

  • Genetics(clinical)


Dive into the research topics of 'Factors influencing men's interest in gene testing for prostate cancer susceptibility'. Together they form a unique fingerprint.

Cite this